Free Trial

Fresenius SE & Co. (OTCMKTS:FSNUY) Sets New 12-Month High - Still a Buy?

Fresenius SE & Co. logo with Medical background

Key Points

  • Fresenius SE & Co. shares reached a new 52-week high of $13.35 during trading, with a daily trading volume of 878 shares.
  • Analysts at Morgan Stanley reaffirmed an "overweight" rating on Fresenius SE & Co., indicating positive sentiment towards the stock.
  • The company reported a quarterly EPS of $0.24, exceeding estimates, and announced a dividend increase to $0.1827 per share, reflecting a solid financial performance.
  • Looking to export and analyze Fresenius SE & Co. data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $13.35 and last traded at $13.35, with a volume of 878 shares trading hands. The stock had previously closed at $12.99.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reiterated an "overweight" rating on shares of Fresenius SE & Co. in a research report on Wednesday.

Get Our Latest Stock Report on FSNUY

Fresenius SE & Co. Price Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.43. The firm has a market capitalization of $29.88 billion, a price-to-earnings ratio of 25.24 and a beta of 0.76. The business has a fifty day moving average of $12.37 and a two-hundred day moving average of $11.42.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.22 by $0.02. Fresenius SE & Co. had a return on equity of 9.33% and a net margin of 5.09%. The firm had revenue of $6.48 billion for the quarter, compared to analyst estimates of $5.83 billion. As a group, research analysts predict that Fresenius SE & Co. will post 0.79 EPS for the current fiscal year.

Fresenius SE & Co. Increases Dividend

The business also recently announced a dividend, which was paid on Wednesday, June 4th. Stockholders of record on Wednesday, May 28th were issued a dividend of $0.1827 per share. This is an increase from Fresenius SE & Co.'s previous dividend of $0.17. The ex-dividend date of this dividend was Tuesday, May 27th. This represents a dividend yield of 148.0%. Fresenius SE & Co.'s payout ratio is currently 33.96%.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fresenius SE & Co. Right Now?

Before you consider Fresenius SE & Co., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. wasn't on the list.

While Fresenius SE & Co. currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines